← Leaderboards
Christopher C. W. Hughes
University Of California Irvine
$22,189,863
Attributed
$34,257,710
Total exposure
25
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,257,710 · 25
By mechanism
R01$10,441,782 · 7
UC4$6,890,666 · 2
UH3$5,347,780 · 2
UG3$5,067,920 · 3
R33$1,904,995 · 1
R21$1,559,518 · 4
Top collaborators
- Maike Sander8 shared
- Steven Carl George7 shared
- Leslie Michels Thompson5 shared
- Karen L Christman3 shared
- Abraham P Lee2 shared
- Maheswari Senthil2 shared
- Marian L Waterman2 shared
- Anna Grosberg1 shared
Most similar at University Of California Irvine
Same institution · by research overlap
- Maike Sander$27,932,599
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsCellsEndothelial CellsTissuesComplexIn VitroResponseMicrofluidicsOrganIn VivoMalignant NeoplasmsIn Vitro ModelBiologyUnited States National Institutes Of HealthBiomedical EngineeringStromal CellsGene ExpressionBlood CapillariesDevicesCapillaryTissue Engineering3-DimensionalInsulinNovel Therapeutics
Grant awards (78)
Bed to bench evaluation of cardiac and vascular impact of OSA$1,296,660
R01 · FY2025 · HL
Studying the mechanisms of initiation and progression of Beta cell death in T1D$1,232,846
UG3 · FY2025 · DK
A vascularized microphysiological system (MPS) platform for modeling peritoneal carcinomatosis$521,240
R01 · FY2025 · CA · contact PI
Repurposing drugs to treat Hereditary Hemorrhagic Telangiectasia: identification using a vascularized HHT on-a-chip microphysiological system platform$78,500
R03 · FY2025 · NS · contact PI
A Vascularized Micro-Organ platform for the study of Brain-BBB-Blood interaction$613,134
R33 · FY2024 · HL · contact PI
A vascularized microphysiological system (MPS) platform for modeling peritoneal carcinomatosis$501,606
R01 · FY2024 · CA · contact PI
In search of synergistic drug interactions in cancer$164,059
R21 · FY2024 · CA · contact PI
A 3D vascularized islet biomimetic to model type 1 diabetes$998,312
UH3 · FY2023 · DK
A Vascularized Micro-Organ platform for the study of Brain-BBB-Blood interaction$638,729
R33 · FY2023 · HL · contact PI
In search of synergistic drug interactions in cancer$205,740
R21 · FY2023 · CA · contact PI
A 3D vascularized islet biomimetic to model type 1 diabetes$1,009,781
UH3 · FY2022 · DK
A Vascularized Micro-Organ platform for the study of Brain-BBB-Blood interaction$653,132
R33 · FY2022 · HL · contact PI
Training Program in Cardiovascular Applied Research and Entrepreneurship$179,318
T32 · FY2022 · HL · contact PI
A 3D vascularized islet biomimetic to model type 1 diabetes$1,009,567
UH3 · FY2021 · DK
Microphysiological systems to model vascular malformations$716,989
UH3 · FY2021 · HL · contact PI
A Vascularized Micro-Organ platform for the study of Brain-BBB-Blood interaction$642,429
R61 · FY2021 · HL · contact PI
Training Program in Cardiovascular Applied Research and Entrepreneurship$179,884
T32 · FY2021 · HL · contact PI
A 3D vascularized islet biomimetic to model type 1 diabetes$1,035,118
UG3 · FY2020 · DK
Microphysiological systems to model vascular malformations$716,989
UH3 · FY2020 · HL · contact PI
A Vascularized Micro-Organ platform for the study of Brain-BBB-Blood interaction$640,807
R61 · FY2020 · HL · contact PI
MIcrophysiological systems to model vascular malformations$179,153
UH3 · FY2020 · HL · contact PI
Training Program in Cardiovascular Applied Research and Entrepreneurship$177,654
T32 · FY2020 · HL · contact PI
Onco-Imaging and Biotechnology Program (OIB)$24,825
P30 · FY2020 · CA · contact PI
A 3D vascularized islet biomimetic to model type 1 diabetes$1,087,069
UG3 · FY2019 · DK
Microphysiological systems to model vascular malformations$716,989
UH3 · FY2019 · HL · contact PI
Training Program in Cardiovascular Applied Research and Entrepreneurship$175,477
T32 · FY2019 · HL · contact PI
Onco-Imaging and Biotechnology Program (OIB)$24,825
P30 · FY2019 · CA · contact PI
Microphysiological systems to model vascular malformations$719,442
UG3 · FY2018 · HL · contact PI
Training Program in Cardiovascular Applied Research and Entrepreneurship$173,352
T32 · FY2018 · HL · contact PI
Onco-Imaging and Biotechnology Program (OIB)$24,825
P30 · FY2018 · CA · contact PI
Modular monitoring of hormone release from human islets$1,981,404
UC4 · FY2017 · DK
Microphysiological systems to model vascular malformations$993,445
UG3 · FY2017 · HL · contact PI
Real-time bioluminescent detection of circulating biomarkers$193,125
R21 · FY2017 · EB · contact PI
Training Program in Cardiovascular Applied Research and Entrepreneurship$160,782
T32 · FY2017 · HL · contact PI
Onco-Imaging and Biotechnology Program (OIB)$14,260
P30 · FY2017 · CA · contact PI
A 3-D biomimetic human islet to model beta cell function in health and disease$961,943
UC4 · FY2016 · DK
(PQD5) Development of in Vitro Vascularized Microtumors for Drug Screening$313,372
R01 · FY2016 · CA · contact PI
Real-time bioluminescent detection of circulating biomarkers$223,030
R21 · FY2016 · EB · contact PI
Training Program in Cardiovascular Applied Research and Entrepreneurship$162,738
T32 · FY2016 · HL · contact PI
A 3-D biomimetic human islet to model beta cell function in health and disease$33,480
UC4 · FY2016 · DK
Onco-Imaging and Biotechnology Program (OIB)$22,102
P30 · FY2016 · CA · contact PI
(PQD5) Development of in Vitro Vascularized Microtumors for Drug Screening$313,372
R01 · FY2015 · CA · contact PI
Training Program in Cardiovascular Applied Research and Entrepreneurship$160,768
T32 · FY2015 · HL · contact PI
A 3-D biomimetic human islet to model beta cell function in health and disease$3,913,839
UC4 · FY2014 · DK
(PQD5) Development of in Vitro Vascularized Microtumors for Drug Screening$303,971
R01 · FY2014 · CA · contact PI
Training Program in Cardiovascular Applied Research and Entrepreneurship$158,850
T32 · FY2014 · HL · contact PI
Molecular Approaches targeted on blocking angiogenesis$324,449
R01 · FY2013 · HL · contact PI
A 3-D in vitro platform of tumor metastasis (PQ24)$318,879
R01 · FY2013 · CA
(PQD5) Development of in Vitro Vascularized Microtumors for Drug Screening$312,400
R01 · FY2013 · CA · contact PI
GROWTH FACTORS & SIGNALING PROGRAM$10,562
P30 · FY2013 · CA · contact PI
Molecular Approaches targeted on blocking angiogenesis$340,808
R01 · FY2012 · HL · contact PI
A 3-D in vitro platform of tumor metastasis (PQ24)$338,175
R01 · FY2012 · CA
Encapsulated engineered microtumors: A platform for high throughput drug screenin$159,335
R21 · FY2012 · CA · contact PI
Molecular Approaches targeted on blocking angiogenesis$344,250
R01 · FY2011 · HL · contact PI
Encapsulated engineered microtumors: A platform for high throughput drug screenin$193,479
R21 · FY2011 · CA · contact PI
Creating a prevascularized thick implantable human tissue$191,250
R21 · FY2011 · HL
GROWTH FACTORS & SIGNALING PROGRAM$10,704
P30 · FY2011 · CA · contact PI
Bidirectional Notch Signaling and Angiogenesis$357,968
R01 · FY2010 · HL · contact PI
Molecular Approaches targeted on blocking angiogenesis$344,250
R01 · FY2010 · HL · contact PI
Creating a prevascularized thick implantable human tissue$229,500
R21 · FY2010 · HL
GROWTH FACTORS & SIGNALING PROGRAM$11,308
P30 · FY2010 · CA · contact PI
Bidirectional Notch Signaling and Angiogenesis$360,463
R01 · FY2009 · HL · contact PI
GROWTH FACTORS & SIGNALING PROGRAM$11,079
P30 · FY2009 · CA · contact PI
Bidirectional Notch Signaling and Angiogenesis$362,690
R01 · FY2008 · HL · contact PI
Bidirectional Notch Signaling and Angiogenesis$364,678
R01 · FY2007 · HL · contact PI
Molecular Approaches Targeted on Blocking Angiogenesis$253,495
R01 · FY2006 · HL · contact PI
Endothelial Cell Regulation of T Cell Activation$289,374
R01 · FY2005 · AI
Molecular Approaches Targeted on Blocking Angiogenesis$259,386
R01 · FY2005 · HL
Endothelial Cell Regulation of T Cell Activation$290,317
R01 · FY2004 · AI
Molecular Approaches Targeted on Blocking Angiogenesis$259,114
R01 · FY2004 · HL
Endothelial Cell Regulation of T Cell Activation$291,183
R01 · FY2003 · AI
Molecular Approaches Targeted on Blocking Angiogenesis$284,611
R01 · FY2003 · HL
Endothelial Cell Regulation of T Cell Activation$291,977
R01 · FY2002 · AI
MOLECULAR APPROACHES TARGETED ON BLOCKING ANGIOGENESIS$230,672
R01 · FY2002 · HL
Endothelial Cell Regulation of T Cell Activation$309,668
R01 · FY2001 · AI
MOLECULAR APPROACHES TARGETED ON BLOCKING ANGIOGENESIS$223,953
R01 · FY2001 · HL
ENDOTHELIAL REGULATION OF T CELL TRANSCRIPTION FACTORS$221,371
R01 · FY2000 · AI
MOLECULAR APPROACHES TARGETED ON BLOCKING ANGIOGENESIS$217,430
R01 · FY2000 · HL